Atacand and Sutent drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atacand (candesartan cilexetil) and Sutent (sunitinib malate). Common drug interactions include pyrexia among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people have when they take Atacand and Sutent. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

What is Sutent?

Sutent has active ingredients of sunitinib malate. It is often used in renal cell carcinoma. eHealthMe is studying from 44,554 Sutent users. Check the latest studies of Sutent.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

63 people who take Atacand and Sutent together, and have interactions are studied.

What are the common drug interactions of Atacand and Sutent, by gender? *:

female:

Pyrexia (fever)
Vomiting
Activities of daily living impaired
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Muscular weakness (muscle weakness)
Vertigo
Pneumonia
Type 2 diabetes mellitus
Metastases to lung (cancer spreads to lung)

male:

Abdominal pain upper
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Salivary gland calculus (stone in salivary gland)
Nausea (feeling of having an urge to vomit)
Decreased appetite
Diarrhoea
Ageusia (loss of taste functions of the tongue)
Blood creatine phosphokinase increased
Blood creatine phosphokinase mb increased
Neoplasm progression (growth of tumour)

What are the common drug interactions of Atacand and Sutent, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Activities of daily living impaired
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Asthma
Back pain
Blood sodium decreased
Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Confusional state
Cough
Drug intolerance (drug sensitivity)

30-39:

n/a

40-49:

Blood creatine phosphokinase increased
Blood creatine phosphokinase mb increased

50-59:

Flushing (the warm, red condition of human skin)
Hepatic lesion
Hypotension (abnormally low blood pressure)
Osteonecrosis (death of bone)
Pruritus (severe itching of the skin)
Pyrexia (fever)
Urticaria (rash of round, red welts on the skin that itch intensely)
Activities of daily living impaired
Anaemia (lack of blood)
Asthenia (weakness)

60+:

Abdominal pain upper
Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
Salivary gland calculus (stone in salivary gland)
Diarrhoea
Decreased appetite
Nausea (feeling of having an urge to vomit)
Ageusia (loss of taste functions of the tongue)
Neoplasm progression (growth of tumour)
Muscular weakness (muscle weakness)
Vertigo

What are the existing conditions these people have? *

Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 18 people, 28.57%
Neoplasm Of Thymus (tumour of thymus): 9 people, 14.29%
Renal Cancer Metastatic (cancer of kidney spreads to other part): 8 people, 12.70%
Renal Cell Carcinoma Stage Unspecified (kidney cancer in unknown stage): 6 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and Sutent?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously